Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:DGX NYSE:DVA NYSE:LH NASDAQ:RCM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDGXQuest Diagnostics$231.05+1.4%$203.23$165.78▼$237.78$25.50B0.58968,512 shs597,760 shsDVADaVita$236.57+0.5%$213.62$101.00▼$239.64$15.19B0.88935,485 shs231,735 shsLHLabcorp$301.00+1.4%$269.38$244.52▼$300.76$24.66B0.89675,767 shs281,725 shsRCMR1 RCM$14.31$14.28$12.56▼$14.32$6.04B0.844.32 million shsN/A7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDGXQuest Diagnostics0.00%+8.15%+8.74%+15.98%+35.44%DVADaVita0.00%-0.62%+8.60%+56.76%+62.35%LHLabcorp0.00%+4.61%+9.05%+12.64%+12.19%RCMR1 RCM0.00%0.00%0.00%0.00%0.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDGXQuest Diagnostics$231.05+1.4%$203.23$165.78▼$237.78$25.50B0.58968,512 shs597,760 shsDVADaVita$236.57+0.5%$213.62$101.00▼$239.64$15.19B0.88935,485 shs231,735 shsLHLabcorp$301.00+1.4%$269.38$244.52▼$300.76$24.66B0.89675,767 shs281,725 shsRCMR1 RCM$14.31$14.28$12.56▼$14.32$6.04B0.844.32 million shsN/A7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDGXQuest Diagnostics0.00%+8.15%+8.74%+15.98%+35.44%DVADaVita0.00%-0.62%+8.60%+56.76%+62.35%LHLabcorp0.00%+4.61%+9.05%+12.64%+12.19%RCMR1 RCM0.00%0.00%0.00%0.00%0.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDGXQuest Diagnostics 2.50Moderate Buy$231.730.30% UpsideDVADaVita 2.13Hold$216.50-8.48% DownsideLHLabcorp 2.80Moderate Buy$315.334.76% UpsideRCMR1 RCM 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest RCM, LH, DGX, and DVA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/24/2026LHLabcorp Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeBuy (B-) ➝ Buy (B)7/24/2026DGXQuest Diagnostics UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$220.00 ➝ $232.007/24/2026DGXQuest Diagnostics MizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$235.00 ➝ $260.007/24/2026DGXQuest Diagnostics Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$225.00 ➝ $250.007/24/2026DGXQuest Diagnostics Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$236.00 ➝ $255.007/23/2026DGXQuest Diagnostics BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$230.00 ➝ $250.007/23/2026DGXQuest Diagnostics Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$245.007/14/2026DVADaVita Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$205.00 ➝ $250.007/13/2026DGXQuest Diagnostics Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$232.00 ➝ $236.007/13/2026LHLabcorp Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$335.00 ➝ $338.007/13/2026LHLabcorp Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$300.00 ➝ $320.00(Data available from 7/27/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDGXQuest Diagnostics$11.04B2.31$15.38 per share15.02$64.78 per share3.57DVADaVita$13.64B1.11$21.82 per share10.84($5.29) per share-44.72LHLabcorp$14.14B1.75$25.19 per share11.95$103.98 per share2.89RCMR1 RCM$2.25B2.68$0.69 per share20.89$6.66 per share2.15Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDGXQuest Diagnostics$992M$9.4224.5319.632.619.18%16.01%7.27%N/ADVADaVita$746.80M$10.7821.9512.880.775.65%-270.37%4.87%8/4/2026 (Estimated)LHLabcorp$876.50M$11.2926.6415.571.976.66%16.29%7.62%7/30/2026 (Estimated)RCMR1 RCM$3.30M-$0.15N/A71.55N/A-2.48%-2.18%-1.10%N/ALatest RCM, LH, DGX, and DVA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/4/2026Q2 2026DVADaVita$3.88N/AN/AN/A$3.50 billionN/A7/30/2026Q2 2026LHLabcorp$4.79N/AN/AN/A$3.71 billionN/A7/23/2026Q2 2026DGXQuest Diagnostics$2.82$3.12+$0.30$2.84$2.97 billion$3.04 billion5/5/2026Q1 2026DVADaVita$2.33$2.87+$0.54$2.87$3.36 billion$3.42 billion4/30/2026Q1 2026LHLabcorp$4.09$4.25+$0.16$3.35$3.51 billion$3.54 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthDGXQuest Diagnostics$3.441.51%+7.34%36.52%14 YearsDVADaVitaN/AN/AN/AN/AN/ALHLabcorp$2.880.97%N/A25.51%N/ARCMR1 RCMN/AN/AN/AN/AN/ALatest RCM, LH, DGX, and DVA DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/9/2026LHLabcorpquarterly$0.721.04%8/28/20268/28/20269/11/20265/19/2026DGXQuest Diagnosticsquarterly$0.861.65%7/8/20267/8/20267/22/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDGXQuest Diagnostics0.721.591.46DVADaVitaN/A1.421.37LHLabcorp0.681.731.54RCMR1 RCM0.761.791.79Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDGXQuest Diagnostics88.06%DVADaVita90.12%LHLabcorp95.94%RCMR1 RCM61.10%Insider OwnershipCompanyInsider OwnershipDGXQuest Diagnostics0.88%DVADaVita1.90%LHLabcorp0.84%RCMR1 RCM36.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDGXQuest Diagnostics57,000110.37 million109.40 millionOptionableDVADaVita78,00064.20 million62.98 millionOptionableLHLabcorp71,00082.00 million81.31 millionOptionableRCMR1 RCM30,000422.39 million266.95 millionOptionableRCM, LH, DGX, and DVA HeadlinesRecent News About These CompaniesR1 Rcm IncJune 30, 2026 | moneycontrol.comRecord Currency Management Participates in Innovative European Bank for Reconstruction and Development (EBRD) -Backed Mongolian Tugrik TransactionJune 19, 2026 | businesswire.comR1 Accelerates Real-Time Adjudication with New Phare OS Intelligence EngineJune 18, 2026 | finance.yahoo.comRCM Services Provider Fellow Health Partners Announces Strategic Investment from Cleargate Capital PartnersJune 16, 2026 | businesswire.comR1 RCM names former Humana executive CIOJune 9, 2026 | beckershospitalreview.comBR1 Appoints Eric Tagliere as Chief Information OfficerJune 9, 2026 | finance.yahoo.comRCM company Coronis Health names new CEOMay 28, 2026 | beckershospitalreview.comBR1 RCM declared Top 50 Best Companies to Work for in India making it the Best in Healthcare Industry by Great Place to Work InstituteMay 22, 2026 | aninews.inAR1 RCM expands operations with new office floor, plans strong workforce growthMay 15, 2026 | telanganatoday.comTR1 RCM Expands Hyderabad OperationsMay 12, 2026 | deccanchronicle.comDR1 RCM launches new facility in cityMay 12, 2026 | thehansindia.comTUPDATE - R1 Announces Phare OS Expansion to Help Providers Navigate Growing Complexity and Margin PressureApril 15, 2026 | finance.yahoo.comR1 Announces Revenue Performance Solutions Powered by Phare OS to Help Providers Navigate Growing Complexity and Margin PressureApril 14, 2026 | finance.yahoo.comR1 RCM launches AI tools for AR recovery, denialsApril 14, 2026 | beckershospitalreview.comBOptum Real and Suki build out collaboration to tackle payment challenges as R1 teams with AI scribe HeidiMarch 20, 2026 | fiercehealthcare.comFR1 and Heidi Announce Strategic Partnership to Improve Revenue Capture for Physician Groups and Healthcare OrganizationsMarch 10, 2026 | finance.yahoo.comR1 RCM sells 340B referral capture businessFebruary 19, 2026 | beckershospitalreview.comBR1 Appoints Andy Brailo as Chief Commercial OfficerFebruary 6, 2026 | finance.yahoo.comR1 RCM taps new chief commercial officerFebruary 5, 2026 | beckershospitalreview.comBR1 Awarded ‘Best in KLAS’ Across Multiple RCM Categories for 2026February 4, 2026 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSK Hynix’s Nasdaq Listing Could Reset the AI Memory TradeBy Thomas Hughes | July 7, 20265 Tech Stocks to Buy on the July PullbackBy Thomas Hughes | June 29, 2026Rocket Lab’s Stock Drop Comes With a Bullish TwistBy Ryan Hasson | July 10, 2026AirJoule Unveils Prime System, Clearing Path to CommercializationBy Thomas Hughes | July 1, 2026These 3 Stocks Offer Investors Exposure to the Functional Beverage BoomBy Chris Markoch | July 6, 2026RCM, LH, DGX, and DVA Company DescriptionsQuest Diagnostics NYSE:DGX$231.04 +3.19 (+1.40%) As of 02:48 PM Eastern This is a fair market value price provided by Massive. Learn more.Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.DaVita NYSE:DVA$236.56 +1.13 (+0.48%) As of 02:48 PM Eastern This is a fair market value price provided by Massive. Learn more.DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.Labcorp NYSE:LH$301.00 +4.23 (+1.43%) As of 02:48 PM Eastern This is a fair market value price provided by Massive. Learn more.Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.R1 RCM NASDAQ:RCMR1 RCM Inc. provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers. The company also offers modular solutions, including functional partnership, an outsourcing solutions for improvements across targeted revenue cycle areas for hospital and physician group customers; revenue recovery, to fast-track payer and patient cash collections; revenue optimization, a solution to uncover missed or underreported revenue; clinical integrity, used to improve documentation and coding accuracy to maximize earned revenue for the services provided; and regulatory navigation, a compliance-first solutions for government reimbursement accuracy, pharmacy savings, and compliance. The company was incorporated in 2003 and is headquartered in Murray, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AMD’s AI Bubble Could Burst Into Explosive Upside Atlassian’s AI Pivot Is Starting to Challenge Wall Street’s Bear Case Apple’s Earnings Setup Puts Its Record Rally and AI Patience to the Test Oil Prices Are Surging and These 4 Stocks Are Cashing In MarketBeat Week in Review – 07/20- 07/24 Telecom Earnings Reveal a Sector That Finally Looks Healthier Forget Tesla: These 2 Earnings Reports Reveal Where the Auto Market Is Heading AMD and Cerebras Create A New Blueprint For Hardware Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
